REHOVOT, Israel, March 13,
2024 /PRNewswire/ -- Lavie Bio Ltd., a
leading ag-biologicals company that develops microbiome-based,
computational-driven bio-stimulant and bio-pesticide novel products
and a subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), today
announced that Ceres Global Ag Corp. ("Ceres") a global
agricultural, energy and industrial products merchandising and
supply chain company, has chosen Lavie Bio as a supplier in its
sustainability programs with grain producers. Ceres will integrate
Lavie Bio's bio-inoculant, YalosTM, into its
regenerative agriculture initiatives across the USA and Canada.
"We believe that regenerative agriculture is an integral part of
addressing climate change and creating positive outcomes for both
our farm partners and our planet", said Carlos Paz, President and CEO at Ceres Global
Ag Corp. "By collaborating with Lavie Bio, we are
well-positioned to foster more efficient growing practices and
continue to offer tailored solutions to strategic customers".
Lavie Bio is focused on transformation of the crop input sector
through the development of biologicals as alternatives for
synthetic products. Lavie Bio developed YalosTM to
seamlessly integrate with farmers' current operational practices.
Using solutions like YalosTM, Ceres' goal is to support
farmers' productivity, the goals of millers, and broader
sustainability goals within the agricultural industry.
Ceres is building scalable regenerative agriculture programs
that deliver value to both the grower and the milling customer in
the spring wheat, durum, and oats segments. Ceres' selection of
YalosTM as an element of its 2024 crop-year program is
consistent with its continuing commitment to support innovation for
grower-friendly crop input and sustainability practices that
satisfy demand for regeneratively-grown products.
Jeff Wildeman, Managing
Director at Ceres Global Ag Corp. commented: "Identifying
and deploying local, scalable solutions that deliver value to both
the grower and the end user while delivering positive environmental
outcomes, is key to regenerative agriculture. We believe that our
collaboration with Lavie Bio provides spring wheat and durum
growers with another tool as they continue to evolve their
production practices."
"We are excited to partner with Ceres, whose extensive presence
in North American agriculture, energy, and supply chains enhances
our impact. Their commitment to regenerative agriculture aligns
with Lavie Bio's mission to produce healthier food and foster a
sustainable environment while increasing productivity and value",
said Amit Noam, CEO at Lavie
Bio. He added, "At Lavie Bio, we understand that achieving our
goals requires collaboration with key players in the food value
chain, and working with Ceres exemplifies the necessary teamwork to
promote sustainable agriculture."
About YalosTM
YalosTM is a microbial based inoculant,
that has been designed to empower plant performance based on its
ability to improve the availability and efficiency of nutrient use,
thereby increasing yield, and improving growers' profitability,
while contributing to environmental sustainability and soil health.
YalosTM is a water dispersible granule (WDG) and
is to be applied as a seed treatment.
About Lavie Bio Ltd.:
Lavie Bio, a subsidiary of Evogene Ltd., aims to improve food
quality, sustainability, and agriculture productivity through the
introduction of microbiome-based ag-biological products. Lavie Bio
utilizes a proprietary computational predictive platform, the BDD
platform, powered by Evogene's proprietary MicroBoost AI
tech-engine, harnessing the power of big data, artificial
intelligence, and advanced informatics, for the discovery,
optimization and development of bio-stimulant and bio-pesticide
products.
For more information, please visit www.lavie-bio.com.
About Evogene Ltd.
Evogene (Nasdaq: EVGN, TASE: EVGN) is a computational biology
company aiming to revolutionize the development of life-science
based products by utilizing cutting edge technologies to increase
probability of success while reducing development time and cost.
Evogene established three unique technological engines -
MicroBoost AI, ChemPass AI and GeneRator
AI – leveraging Big Data and Artificial Intelligence and
incorporating deep multidisciplinary understanding in life
sciences. Each technological engine is focused on the discovery and
development of products based on one of the following core
components: microbes (MicroBoost AI), small molecules
(ChemPass AI), and genetic elements (GeneRator AI).
Evogene uses its technological engines to develop products through
subsidiaries and with strategic partners. Currently, Evogene's main
subsidiaries utilize the technological engines to develop human
microbiome-based therapeutics by Biomica Ltd., medical cannabis
products by Canonic Ltd., ag-chemicals by AgPlenus Ltd. and
ag-biologicals by Lavie Bio Ltd. For more information, please
visit: www.evogene.com
Investor Relations Contact
Rachel Pomerantz Gerber I Head of Investor
Relations at Evogene
rachel.pomerantz@evogene.com I Tel: +972-8-9311901
About Ceres Global Ag Corp.
Ceres and its subsidiaries add value across agricultural, energy
and industrial supply chains through efficient sourcing, storing,
transporting and marketing of high–quality agricultural
commodities, value– added products and raw materials. Leveraging
its network of commodity logistics centers and team of industry
experts, Ceres connects farmers to customers around the world.
Ceres is headquartered in Golden
Valley, Minnesota, and together with its affiliated
companies, operates 11 locations across Saskatchewan, Manitoba, Ontario, and Minnesota. These facilities have an aggregate
grain and oilseed storage capacity of approximately 29 million
bushels.
Ceres has a 50% interest in Savage Riverport, LLC (a joint
venture with Consolidated Grain and Barge Co.), a 50% interest in
Berthold Farmers Elevator, LLC (a joint venture with The Berthold
Farmers Elevator Company), a 50% interest in Farmers Grain, LLC (a
joint venture with Farmer's Cooperative Grain and Seed
Association), a 50% interest in Gateway Energy Terminal (an
unincorporated joint venture with Steel Reef Infrastructure Corp.),
a 25% interest in Stewart Southern Railway Inc. (a short–line
railway located in southeast Saskatchewan with a range of 130 kilometers),
and a 17% interest in Canterra Seed Holdings Ltd. (a Canada–based
seed development company).
For more information about Ceres, please visit
www.ceresglobalagcorp.com
Forward Looking Statements
This press release contains "forward-looking statements"
relating to future events. These statements may be identified by
words such as "may", "could", "expects", "intends", "anticipates",
"plans", "believes", "scheduled", "estimates" or words of similar
meaning. For example, Lavie Bio and Evogene are using
forward-looking statements in this press release when they discuss
the ability of the regenerative agriculture to addressing climate
change, the ability of Lavie Bio to transform the crop input sector
through the development of biologicals as alternatives for
synthetic products. Such statements are based on current
expectations, estimates, projections, and assumptions, describe
opinions about future events, involve certain risks and
uncertainties which are difficult to predict and are not guarantees
of future performance. Therefore, actual future results,
performance, or achievements of Evogene and its subsidiaries may
differ materially from what is expressed or implied by such
forward-looking statements due to a variety of factors, many of
which are beyond the control of Evogene and its subsidiaries,
including, without limitation, the current war between
Israel and Hamas and any worsening
of the situation in Israel such as
further mobilizations or escalation in the northern border of
Israel, and those risk
factors contained in Evogene's reports filed with the applicable
securities authorities. In addition, Evogene and its
subsidiaries rely, and expect to continue to rely, on third parties
to conduct certain activities, such as their field-trials and
pre-clinical studies, and if these third parties do not
successfully carry out their contractual duties, comply with
regulatory requirements or meet expected deadlines, Evogene and its
subsidiaries may experience significant delays in the conduct of
their activities. Evogene and its subsidiaries disclaim any
obligation or commitment to update these forward-looking statements
to reflect future events or developments or changes in
expectations, estimates, projections.
Logo: https://mma.prnewswire.com/media/1947468/Evogene.jpg
Logo:
https://mma.prnewswire.com/media/945133/lavie_bio_Logo.jpg
View original
content:https://www.prnewswire.com/news-releases/lavie-bio-and-ceres-global-ag-corp-collaborate-to-include-yalostm-bio-inoculant-in-regenerative-agriculture-initiatives-in-north-america-302088035.html
SOURCE Lavie Bio